JG
RXII

Jefferies Group’s GALENA BIOPHARMA INC COM RXII Stock Holding History

Jefferies Group’s Portfolio RXII Stock Details RXII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-50,000
Closed -$18K – 2710
2016
Q3 		$18K Hold
50,000
– – ﹤0.01% 2141
2016
Q2 		$23K Hold
50,000
– – ﹤0.01% 2027
2016
Q1 		$68K Hold
50,000
– – ﹤0.01% 2015
2015
Q4 		$74K Hold
50,000
– – ﹤0.01% 2089
2015
Q3 		$79K Buy
+50,000
New +$79K ﹤0.01% 2066

Jefferies Group's RXII Position: Q4 2014 in Review

Jefferies Group sold out of GALENA BIOPHARMA INC COM (RXII) in Q4 2014, closing a stake of 16,930 shares — an estimated $35K sold.

Jefferies Group first reported a position in RXII in Q3 2013 and held it in 2 quarters. The position peaked at $72K in Q3 2013. 79 funds tracked by Wall St. Rank hold RXII as of Q4 2014.

  • Jefferies Group reported no remaining GALENA BIOPHARMA INC COM position as of Q4 2014 after selling out during the quarter.
  • Jefferies Group sold 16,930 GALENA BIOPHARMA INC COM shares in Q4 2014, an estimated $35K.
  • Jefferies Group first reported a position in GALENA BIOPHARMA INC COM in Q3 2013 and held it in 2 quarters.
  • Jefferies Group's GALENA BIOPHARMA INC COM position peaked at $72K in Q3 2013.
  • 79 funds tracked by Wall St. Rank held GALENA BIOPHARMA INC COM as of Q4 2014.

Based on Jefferies Group's 13F filing for Q4 2014, filed 17 Feb 2015.